What is a blockbuster medicine?
Blockbuster is a medicine that generates more than $ 1 billion in US dollars (USD) every year. Since 2011, there have been roughly a dozen of these drugs on the market, a mixture of regulations and over -the -counter drugs. Three factors determine whether a new drug will become a blockbuster medicine: the need for population, marketing for the public and marketing for doctors. As long as these conditions are met, the pharmaceutical society can expect large income until the patent for the drug is reached. Atorvastatin, also known as a lipitor, treats high cholesterol. Klopidogrel, also known as Plavix, is an anti -paying agent that is also used to treat high cholesterol. Enoxaparin, also known as LOVENOX, is an anticoagulant used to treat blood clots. Although these drugs are produced by various pharmaceutical companies, three companions make each blockbuster drug.
The need for a population is a primary factor in whether a new drug will become a blockbuster. The three drugs above primarily fill in the need. Given that in r rObesity and types of two diabetes increase, and secondary conditions such as high cholesterol and coronary heart disease are also developing. Each of these three drugs is used in the treatment of these conditions. However, the success of the drug depends on much more than its need for society.
Direct-to-Consumer (DTC) Marketing of prescription drugs is legal only in the United States and New Zealand. Because the first is one of the largest prescription consumers in the world, pharmaceutical companies use television and press advertising in the same way as other companies selling a product. The ads not only try to convince individuals that they need to treat their condition, but that they need specific medicines that the ad is to sell. These ads have created huge income for pharmaceutical companies; The number of blockbuster drugs would be much less if these ads did not exist.
the last stepEM When creating a blockbuster medicine, marketing of new medicines for doctors and other medical processions is directly marketing. Pharmaceutical sales representatives visit private practices, hospitals and nursing homes to sell the latest products of their company. After meeting with doctors and nurses, representatives usually leave samples that doctors can give to their patients. The aim is that after the patient uses a free sample of drugs, he will continue to use medicines.
In addition to increasing income, pharmaceutical companies perform these aggressive marketing techniques for another reason. If a new drug becomes a blockbuster drug, a pharmaceutical company that produces it is about ten years before the patent. After this moment, other companies can produce a general version of the drug and sell it for less. Given that pharmaceutical companies know that their blockbuster drug profits will eventually drop, their goal is to sell as much drugs as possible as they can in the affordable time.